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Mouse hepatitis virus (MHV) causes encephalitis and demyelination in the central nervous system (CNS) of susceptible rodents. Astrocytes are
one of the major targets for MHV infection in the CNS, and respond to MHV infection by expressing diverse molecules that may contribute to
CNS pathogenesis. Here we characterized the activation of an immediate-early transcription factor Egr-1 by MHV infection in an astrocytoma cell
line. We found that the expression of Egr-1 was dramatically increased following virus infection. Using various inhibitors of mitogen-activated
protein kinases, we identified that the extracellular signal-regulated kinases 1/2 were involved in the activation of Egr-1 transcription by MHV
infection. Experiments with ultraviolet light-inactivated virus revealed that the induction of Egr-1 did not require virus replication and was likely
mediated during cell entry. We further found that over-expression of Egr-1 suppressed the expression of BNip3, a pro-apoptotic member of the
Bcl-2 family. This finding may provide an explanation for our previously observed down-regulation of BNip3 by MHV infection in astrocytoma
cells (Cai, Liu, Yu, and Zhang, Virology 316:104–115, 2003). Furthermore, knockdown of Egr-1 by an siRNA inhibited MHV propagation,
suggesting the biological relevance of Egr-1 induction to virus replication. In addition, the persistence/demylinating-positive strains (JHM and
A59) induced Egr-1 expression, whereas the persistence/demylinating-negative strain (MHV-2) did not. These results indicate a correlation
between the ability of MHVs to induce Egr-1 expression and their ability to cause demyelination in the CNS, which may suggest a potential role
for the induction of Egr-1 in viral pathogenesis.
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Murine coronavirus mouse hepatitis virus (MHV) is a
member of the family Coronaviridae, which is a group of
enveloped, single-stranded, and positive-sense RNA viruses.
MHV utilizes its surface spike (S) glycoprotein to initiate
infection by interacting with a specific cellular receptor
(Williams et al., 1991). This interaction triggers a conforma-
tional change of the spike, resulting in exposure of its fusogenic
domain, which further triggers fusion between viral envelope
and plasma membrane and subsequent release of the nucleo-
capsid into cytoplasm (Matsuyama and Taguchi, 2002). In some
MHV strains, virus entry occurs following receptor-mediated
endocytosis (Nash and Buchmeier, 1997). The precise process
of virus uncoating is not clear, but is believed to involve⁎ Corresponding author. Fax: +1 501 686 5359.
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doi:10.1016/j.virol.2006.07.012dephosphorylation of the nucleocapsid (N) protein and
dissociation of N protein from viral genomic RNA (Kalicharran
et al., 1996). The incoming viral genomic RNA is then
translated into the viral polymerase polyprotein of more than
800 kDa that is essential for subsequent viral replication and
transcription.
MHV can infect rodents and cause hepatitis, nephritis,
enteritis, and central nervous system (CNS) diseases (Sebesteny
and Hill, 1974; Herndon et al., 1975). In the CNS, MHV
infection causes encephalitis and demyelination. Because the
pathology of demyelination caused by MHV infection resem-
bles those of multiple sclerosis (MS) seen in humans, MHV has
been extensively used as an animal model for MS and other
neurodegenerative diseases (Lampert et al., 1973; Herndon et
al., 1977). Following MHV infection, mice usually develop
acute encephalitis and demyelination during the first week of
infection (Woyciechowska et al., 1984). Most of the viruses are
cleared from the CNS at the end of the second week post-
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demyelination then develops and reaches to a peak at around 30
days p.i. At this time, however, infectious virus can no longer be
isolated but viral RNAs are still detectable in the CNS (Fleming
et al., 1993; Adami et al., 1995). Viral RNA can persist in the
CNS, especially in astrocytes, for an extended period of time
(Adami et al., 1995; Perlman and Ries, 1987; Rowe et al.,
1998).
Astrocytes play important roles in supporting the nervous
system and controlling the chemical and ionic environment of
the CNS. Astrocytes can be stimulated to produce diverse pro-
inflammatory molecules such as cytokines, chemokines, and
nitric oxide (Van Wagoner and Benveniste, 1999; Huang et al.,
2000; Chen and Swanson, 2003). It has been shown that MHV
infection can induce the expression of transforming necrosis
factor (TNF)-α, interleukin (IL)-6, matrix metalloproteinases,
and inducible nitric oxide synthase (iNOS) in astrocytes
(Kyuwa et al., 1994; Joseph et al., 1993; Zhou et al., 2001;
Grzybicki et al., 1997). Infection of astrocytes with MHV may
thus modulate the development of the CNS pathology and alter
the course of the disease. In vitro, MHV can persist in the DBT
astrocytoma cell line, in the progenitor oligodendrocyte/
astrocyte CG-4 cells and in a fibroblast 17Cl-1 cell line (Chen
and Baric, 1995; Liu and Zhang, 2005; Maeda et al., 1995;
Sawicki et al., 1995). However, the precise mechanisms of viral
persistence in animal CNS and in cultured cell lines are not
known. Previous studies have suggested that alteration of
receptor expression in DBT and 17Cl-1 cells by MHV infection
may facilitate viral persistence (Chen and Baric, 1996;
Porntadavity et al., 2001; Sawicki et al., 1995). In our previous
analysis on cellular gene expression in MHV-infected DBTcells
using the DNA microarray technology, we suggested that
alterations of the expression of cellular genes, in addition to the
receptor down-regulation, might play an important role in
establishing persistent infection in DBT cells (Cai et al., 2003).
One of such candidate cellular factors is the early growth
regulator-1 (Egr-1). Egr-1 is also named as nerve growth factor
induced-A (NGFI-A), zif268, TIS8, or Krox24, which is an
immediate early gene, the prototype of a family of zinc-finger
transcription factors (Waters et al., 1990; Changelian et al.,
1989; Christy and Nathans, 1989; Varnum et al., 1989; Lemaire
et al., 1990). Egr-1 can be rapidly induced by diverse stimuli,
including growth factors, hormones, cytokines, neurotransmit-
ters and injurious stimuli through different mitogen-activated
protein kinases (MAPKs) pathways, including the extracellular
signal-regulated kinase (ERK), c-Jun NH2-terminal kinase
(JNK), and p38 MAPK pathways depending on the stimuli
(Sukhatme et al., 1988; Cao et al., 1990, 1992; Lim et al., 1998;
Milbrandt, 1987; Honkaniemi et al., 1995). For example, Egr-1
gene expression is induced through ERK signal pathway by
cytokines and growth factors, while it is induced via p38 and
JNK pathways by stress treatment such as heat shock, sodium
arsensite, ultraviolet, radiation, and anisomycin (Santiago et al.,
1999; Liu and Zhang, 2005). As a transcription factor, Egr-1
contains a DNA binding domain, which binds specifically to the
consensus binding sequence GCG (T/G) GGGCG (Cao et al.,
1990). Egr-1 can induce the expression of a number of genes,such as platelet-derived growth factor (PDGF)-A and -B,
macrophage colony-stimulating factor (M-CSF), TNF-α, IL-2,
and intercellular adhesion molecule (ICAM)-1 (Delbridge and
Khachigian, 1997; Khachigian et al., 1996; Harrington et al.,
1991; Kramer et al., 1994; Skerka et al., 1995; Maltzman et al.,
1996). All of these genes contain one or more Egr-1 consensus
binding sites within their promoter regions. Thus, Egr-1 is
involved in regulation of a variety of cellular processes,
including cell proliferation, differentiation, neuronal plasticity,
vascular wound response, and cancer progression (Hill and
Treisman, 1995; Nguyen et al., 1993; James et al., 2004;
Khachigian et al., 1996; Kobayashi et al., 2002). For examples,
it has been demonstrated that astrocyte growth is regulated by
neuro-peptides through basic fibroblast growth factor and Egr-1
(Hu and Levin, 1994; Biesiada et al., 1996); Egr-1 was
significantly increased in prostate carcinoma and treatment with
anti-Egr-1 anti-sense dramatically inhibited the prostate cancer
progression, suggesting a role for Egr-1 in the development of
prostate cancer (Eid et al., 1998; Baron et al., 2003a,b).
In the present study, we investigated the expression of Egr-1
in MHV-infected DBT cells, the signal pathways that induce
Egr-1 expression, and the potential outcome of Egr-1 expression
on cell survival and viral persistence. We found that both
mRNA and protein levels of Egr-1 were significantly induced in
DBT cells by MHV infection, which was mediated through the
ERK signal pathway. Moreover, the ability of MHV strains to
induce Egr-1 expression was correlated with their ability to
cause persistent infection in the CNS. Our data may thus
suggest a link between the induction of Egr-1 gene expression
and the establishment of viral persistence in DBT cells. These
findings may also provide insight into the mechanisms by which
MHV establishes persistence in the DBT cells and in animal
CNS.
Results
Induction of the transcription factor Egr-1 expression in
astrocytoma DBT cells by MHV infection
In a previous study, we performed DNA microarray
analysis to determine the alteration of cellular gene expression
by MHV infection in DBT cells (Cai et al., 2003). We found
that the expression of a substantial number of genes was
altered by MHV infection. Among them, the expression of the
transcription factor Egr-1 was increased more than 9-fold
(data not shown). To verify the microarray data, we used RT-
PCR to directly determine the Egr-1 mRNA during the course
of virus infection. DBT cells were infected with MHV-JHM
strain at an m.o.i. of 5 or mock-infected. The intracellular
RNAs were isolated at various time points p.i. cDNAs were
synthesized by RT with a random primer and were amplified
by PCR using a primer pair specific to Egr-1 or β-actin as an
internal control. As shown in Fig. 1A, the cDNAs represent-
ing Egr-1 gene were not induced at 4 h p.i., but were
dramatically increased (a 46-fold increase) at 8 h p.i., and
peaked at 12 h p.i. At 16 h p.i., the level of Egr-1 mRNA
appeared to decline. In contrast, the level of β-actin mRNA
Fig. 2. Egr-1 mRNA expression was induced by both live and UV-irradiated
viruses. DBTcells were infected with live or UV-irradiated MHV-JHM or mock-
infected. Intracellular RNAs were isolated at 8 and 12 h p.i. RT-PCR was
performed to detect Egr-1 mRNA. β-actin was used as an internal control. The
RT-PCR products were analyzed by electrophoresis on 2% agarose gel and
visualized by staining with ethedium bromide. Images were taken with the
digital camera (UVP). The intensity of each band was quantified and the ratio of
Egr-1 to β-actin for each sample was presented as E/A ratio. The data are
representative of three independent experiments. M, RNAs from mock-infected
cells; V, RNAs from MHV-JHM-infected cells; UV-V, RNAs from UV-
irradiated MHV-JHM-infected cells.
Fig. 1. Induction of transcription factor Egr-1 expression by MHV-JHM
infection. DBT cells were infected with MHV-JHM strain at an m.o.i. of 5 or
mock-infected. For mRNA detection (A), intracellular RNAs were isolated at
various time points p.i. as indicated. RT-PCR was performed to detect the
mRNAs of Egr-1 gene and β-actin, the latter of which was served as an internal
control. The RT-PCR products were analyzed by electrophoresis on 2% agarose
gel and visualized by staining with ethidium bromide. Images were taken with
the digital camera (UVP). For protein detection (B), cells were lysed at various
time points p.i. as indicated. Equal amounts of cell lysates were separated by
polyacrylamide gel (9%) electrophoresis. Proteins were then transferred to
nitrocellulose membranes and were detected with an Egr-1 antibody and
enhanced chemiluminescence by Western blot analysis. An aliquot of an equal
amount of cell lysates from each sample was used for analyzing the β-actin
protein with the β-actin antibody as an internal control. The data are
representative of three independent experiments. M, lysates from mock-infected
cells; V, lysates from MHV-JHM-infected cells.
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demonstrate that the expression of Egr-1 gene was induced by
MHV infection at the transcriptional level, which confirmed
the finding obtained from microarray analysis.
Next, Western blot was employed to detect Egr-1 protein.
Following infection, DBT cells were harvested and lysed at
various time points p.i. Immunoblotting with the anti-Egr-1
antibody or anti-β-actin antibody was performed. As expected,
a significant increase (≈20-fold) in Egr-1 protein was detected
in virus-infected cells at 8 and 12 h p.i. but not at 4 h p.i., as
compared to those in mock-infected cells (Fig. 1B). Taken
together, these data demonstrate that Egr-1 gene expression was
significantly induced in DBT cells by MHV infection.
Both live and UV-inactivated MHVs were capable of inducing
Egr-1 gene expression
To determine whether the induction of Egr-1 expression
requires viral replication, UV-irradiated virus was used in
comparison with live virus infection. UV-irradiated virus can
bind to cell receptors and penetrate into the cells, but is unable
to replicate. DBTcells were infected with UV-irradiated virus or
live virus, or mock-infected. Total intracellular RNAs were
isolated at 8 and 12 h p.i. RT-PCR was performed to determine
the expression of Egr-1 mRNA. As shown in Fig. 2, Egr-1
mRNA was induced by infection with the live virus at 8 and12 h p.i. Although infection with UV-inactivated virus did not
significantly induce Egr-1 expression at 8 h p.i., it did so by 12 h
p.i. (≈20-fold increase as compared to mock-infected cells),
indicating that virus replication is not absolutely required for
Egr-1 induction. The data also suggest that virus entry alone is
sufficient to induce Egr-1 expression, albeit with a low
efficiency.
The induction of Egr-1 was mediated by virus infection through
the ERK signal pathway
It has been previously reported that both p38 and JNK
MAPKs were activated in DBT cells infected with MHV-JHM
during viral replication (Banerjee et al., 2002). It has also been
shown that ERK was activated in peritoneal exudative macro-
phages at a very early time point of infection (5 min p.i.) with
MHV-3 (McGilvray et al., 1998). As described in the
introduction, Egr-1 can be induced by all three MAPK
pathways. It was therefore interesting to determine whether
MHV-induced Egr-1 gene expression was mediated through
one or more of the three MAPK signaling pathways. To address
this question, we determined the activation of Egr-1 by MHV
infection following the treatment of cells with inhibitors
specifically inhibiting one of the three MAPK pathways.
UO126 is the inhibitor of the ERK pathway, whereas
SB203580 and SP600125 are the inhibitors of p38 and JNK
pathways, respectively (Cuenda et al., 1995; Bennett et al.,
2001; Favata et al., 1998). DBT cells were treated with UO126
(25 μM or 50 μM), SB203580 (40 μM), SP600125 (40 μM), or
DMSO (as a negative control) for 1 h prior to infection, during
and throughout the infection. Cells were infected with MHV-
JHM at an m.o.i. of 5 or mock-infected. Intracellular RNAs
were harvested at 12 h p.i., and Egr-1 mRNAs were detected by
RT-PCR. As shown in Fig. 3A, treatment of cells with UO126 at
either concentration (25 μM or 50 μM) almost completely
blocked the induction of Egr-1 by MHV infection. By contrast,
treatment with SB203580 or SP600125 failed to block Egr-1
induction by MHV infection. To verify this finding, we used a
Fig. 4. Activation of ERK signaling pathway by MHV infection. DBTcells were
infected with purified MHV-JHM at an m.o.i. of 5 or mock-infected. After 1 h
binding at 4 °C, the viral inoculums were removed and fresh medium without
serum were added to the plates. The cells were harvested and lysed following
incubation at 37 °C for various time points p.i. as indicated. Equal amounts of
cell lysates were separated by polyacrylamide gel (10%) electrophoresis.
Proteins were then transferred to nitrocellulose membranes and were detected
with an antibody specific for phosphorylated-forms of ERK1/2 (ERK1/2-P) and
enhanced chemiluminescence by Western blot analysis. An aliquot of an equal
amount of cell lysates from each sample was used for analyzing total ERK1/2
(ERK1/2-T) with an antibody specific for ERK1/2 as an internal control. The
data are representative of three independent experiments. M, lysates from mock-
infected cells; V, lysates from MHV-JHM-infected cells.
Fig. 3. The induction of Egr-1 gene by MHV infection was mediated through the
ERK signal pathway. (A) DBT cells were pre-treated with MEK inhibitor
UO126 (I: 25 μM or II: 50 μM), JNK inhibitor SP600125 (40 μM), p38 inhibitor
SB203580 (40 μM), or DMSO for 1 h prior to infection. These treated cells were
then infected with MHV-JHM at an m.o.i. of 5 or mock-infected. At 12 h p.i., the
intracellular RNAs were isolated and were subjected to RT with a random
primer. cDNAs were amplified by PCR using the primer pair specific to Egr-1 or
β-actin (as an internal control). The drugs were present in the medium
throughout the 12 h period. The data are representative of three independent
experiments. M, RNAs from mock-infected cells; V, RNAs from MHV-JHM
infected cells. (B) As in panel A, except that the ERK1/2 inhibitor CI-1040 (CI-
I: 3 μM; CI-II: 5 μM) was used and that the concentration of UO126 was 50 μM
in this experiment.
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specific and potent to the ERK pathway (Sebolt-Leopold et al.,
1999). We found that treatment of DBT cells with CI-1040 (3–
5 μM) blocked the induction of Egr-1 by MHV infection to a
level similar to those treated with UO126 at 50 μM (Fig. 3B).
We thus conclude that induction of Egr-1 gene expression by
MHV infection was likely mediated through the MEK-ERK
signal pathway.
Activation of the ERK signal pathway by MHV infection
Although the above studies with MAPK inhibitors pointed
out the involvement of ERK pathway in Egr-1 induction, it is
not known whether the ERK pathway is actually activated by
MHV infection. To provide direct evidence for the activation of
the ERK pathway, we determined the phosphorylation status of
ERK1 (p44) and ERK2 (p42) following MHV infection.
Because it is well known that serum can stimulate ERK
activation, DBT cells were subjected to serum-starvation for
24 h prior to virus infection. DBT cells were then infected with
gradient-purified MHV-JHM at an m.o.i. of 5 or mock-infected.
After 1 h binding at 4 °C, the viral inoculums were removed.
Cells were fed with fresh medium without serum and were
incubated at 37 °C. At various time points as indicated, cell
lysates were prepared for determination of ERK1/2 phosphor-
ylation by Western blot analysis. As shown in Fig. 4, although
ERK1/2 phosphorylation was detected in both virus-infected
and mock-infected cells at all time points p.i., the levels of
phosphorylation were significantly higher in virus-infected cellsthan in mock-infected cells from 5 to 120 min p.i. Moreover, no
increase in ERK1/2 phosphorylation was detected in virus-
infected cells at 0 min p.i. Taken together, these data indicate
that the ERK signal pathway was indeed specifically activated
by MHV-JHM infection.
Over-expression of Egr-1 repressed BNip3 promoter activity
We have demonstrated in a previous study that the
expression level of the pro-apoptotic gene BNip3 was down-
regulated by MHV infection (Cai et al., 2003). A recent report
showed that BNip3 gene expression was down-regulated by
over-expression of Egr-1 in prostate cancer cells (Virolle et al.,
2003). Therefore, it is of interest to determine whether the
down-regulation of BNip3 in MHV-infected DBT cells is also
mediated through the induction of the transcription factor Egr-1.
First, we determined the BNip3 promoter activity by using the
luciferase reporter assay (Cai et al., 2003). We expressed Egr-1
protein transiently in DBT cells by cotransfecting pBS-CMV-
Egr-1, which contains the Egr-1 ORF under the control of a
CMV promoter, and pGL3-BNip3 reporter plasmid (Bruick,
2000; Cai et al., 2003). After 20 h post-transfection, cell lysates
were harvested and luciferase activity determined. Results
showed that transient cotransfection with an increased amount
of Egr-1-expressing plasmid (ranging from 20 to 500 ng per
well) exhibited an increased inhibitory effect on BNip3
promoter activity by 2 to 45% (Fig. 5A). This inhibition
appeared to be specific for Egr-1 because cotransfection with
the empty vector pBS-CMV (without expressing the Egr-1) did
not have any effect on luciferase activity (Fig. 5A). The specific
inhibitory effect of the expressed Egr-1 on pGL3-BNip3
reporter was further examined in a cotransfection experiment,
in which pBS-CMV-Egr-1 or pBS-CMV and the pSV-β-gal
reporter plasmid (which is under the control of an SV40
promoter) were cotransfected into DBT cells. At 24 h post-
transfection, β-gal activity was determined. In stark contrast to
the result for pGL3-BNip3 reporter (Fig. 5A), the β-gal activity
was virtually unaffected by the expression of Egr-1 (Fig. 5B).
Fig. 5. Inhibition of the BNip3 promoter activity by over-expression of Egr-1. (A) BNip3 promoter activity in transiently transfected cells. DBT cells were transiently
cotransfected with the Egr-1 expression plasmid (pBS-CMV-Egr-1) or empty vector (pBS-CMV) at an amount of 0, 20, 100, or 500 ng per well and pGL3-BNip3
reporter plasmid at 500 ng per well. After 20 h post-transfection, cell lysates were harvested, and the luciferase activity was measured. The relative luciferase activity in
pBS-CMV-Egr-1-expressing cells is indicated as percentage of the luciferase activity expressed from pBS-CMV-transfected cells, which was set as 100%. Data are the
average of a triplicate experiment and are representative of 3 independent experiments. (B) Effect of Egr-1 on SV40 promoter activity. The experiments were
performed exactly as in panel A except that the cotransfecting reporter plasmid is pSV-β-gal instead of pGL3-BNip3. (C) Stable expression of Egr-1 in DBTcells. DBT
cells were transfected with the Egr-1 expression plasmid (pcDNA3-Egr1) or with empty vector (pcDNA3). Following selection with G418 for more than 1 month, two
clones stably expressing Egr-1 were obtained. The expression levels of these two clones were determined by Western blot with an antibody specific to Egr-1. β-actin
protein serves as an internal control. (D) BNip3 promoter activity in Egr-1-stable expressing cells. Equal numbers of cells from these two cloned cells or cells stably
transfected with pcDNA3 empty vector were cotransfected with pGL3-BNip3 reporter plasmid and pSV-β-gal plasmid, the latter of which was used as a control for
transfection efficiency. After 24 h post-transfection, the luciferase activity and β-gal activity were measured. The relative luciferase activity in Egr-1-expressing cells
(Egr1-1 and Egr1-2) is indicated as percentage of the luciferase activity expressed from pcDNA3-transfected cells, which was set as 100%. The luciferase activity was
normalized with β-gal activity. Data are the average of three independent experiments and error bars denote standard deviation.
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promoter activity.
To further confirm these results, we established cell lines that
stably express Egr-1 protein. We tested two cell clones, which
expressed different amounts of Egr-1 protein. Clone #2, termed
Egr-1–2, expressed higher level of Egr-1 protein than clone #1,
termed Egr-1–1, which expressed almost the same amount of
Egr-1 protein as the cells stably transfected with the empty
vector pcDNA3 plasmid (Fig. 5C). Equal numbers of these
cloned cells were cotransfected with pGL3-BNip3 reporter
plasmid and pSV-β-gal plasmid, the latter of which served as acontrol for transfection efficiency as well as for specificity. At
24 h post-transfection, luciferase and β-gal activities in the cells
were determined, and the luciferase activity was normalized to
β-gal activity, which was essentially unaffected by the
cotransfection. As shown in Fig. 5D, BNip3 promoter activity
was decreased approximately 45% in Egr-1–2 clone, while it
decreased only 7% in Egr-1–1 clone as compared to those in
vector-control cells (lane pcDNA3). These results demonstrate
that over-expression of Egr-1 repressed the expression of the
pro-apoptotic BNip3 gene, thus suggesting that the previously
observed down-regulation of BNip3 expression in DBT cells by
Fig. 6. Effect of Egr-1 knockdown on virus propagation and cell survival. (A)
Effect of Egr-1-siRNA on Egr-1 expression. DBT cells were transfected with
Egr-1-siRNA or EGFP-siRNA for 60 h, and then infected with MHV or
mock-infected with PBS. Cells were lysed at 16 h p.i. and proteins were
detected by Western blot with anti-Egr-1 or anti-β-actin antibodies (A). Virus
titers were determined by virus plaque assay at 16 h p.i. and were expressed
as mean±standard deviation (SD) of three experiments (B). (C) Apoptosis
was assessed by determining the apoptotic nuclei following propidium iodide
staining, and was expressed as mean percentage of the cell population and SD
of three experiments. Statistical analysis indicates significance between the
Egr-1 knockdown cells and the control cells (p=0.037).
Fig. 7. Differential induction of Egr-1 expression by different MHV strains. (A)
Expression of Egr-1 mRNA. DBT cells were infected with different strains of
MHVs (including MHV-JHM, A59 and MHV2) or mock-infected. Total
intracellular RNAs were isolated at various time points p.i. as indicated. RT-PCR
was performed to detect the Egr-1 mRNA. β-actin was used as an internal
control. The RT-PCR products were analyzed by electrophoresis on 2% agarose
gel and visualized by staining with ethedium bromide. Images were taken with
the digital camera (UVP). Lanes 1, 5, 9, and 13: RNAs frommock-infected cells;
Lanes 2, 6, 10, and 14: RNAs from cells infected with MHV-JHM; Lanes 3, 7,
11, and 15: RNAs from cells infected with MHV-A59; Lanes 4, 8, 12, and 16:
RNAs from cells infected with MHV-2. The intensity of each band was
quantified by densitometry (UVP), which is indicated as relative amount (rel.
amt) shown beneath each lane. (B) Detection of Egr-1 protein. DBT cells were
infected as in panel A. Cells were harvested and lysed at 12 h p.i. Equal amounts
of the cell lysates were separated by polyacrylamide gel (9%) electrophoresis.
Western blot was performed to detect Egr-1 and β-actin proteins by using an
antibody specific to Egr-1 and β-actin, respectively. The intensity of each band
was quantified and the relative quantity was expressed as a ratio of Egr-1 to β-
actin (E/A ratio) for each sample.
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Role of Egr-1 in virus propagation and cell survival
To establish the biological relevance of the Egr-1 induction,
we used an siRNA specific to Egr-1 to knockdown Egr-1 in
DBT cells. Cells were transfected with an Egr-1-siRNA or a
non-specific EGFP-siRNA, the latter of which serves both as anegative control and for monitoring the transfection efficiency.
At various times post-transfection, the protein level of Egr-1
was monitored by Western blot analysis. A representative result
obtained at 60 h post-transfection is shown in Fig. 6A. In the
absence of virus infection, the Egr-1 level was significantly
lower in Egr-1-siRNA-transfected cells than in EGFP-siRNA-
transfected cells, demonstrating the effectiveness and specificity
of the Egr-1-siRNA. Similarly, Egr-1 expression was effectively
blocked by Egr-1-siRNA but not by EGFP-siRNA even in the
presence of virus infection. Egr-1 protein was much higher in
virus-infected cells than in mock-infected cells when the cells
were transfected with the EGFP-siRNA, further confirming that
MHV infection induces Egr-1 expression. We then determined
the effect of Egr-1 knockdown on virus propagation. Indeed,
knockdown of Egr-1 expression by Egr-1-siRNA exhibited a
detrimental effect on virus propagation, reducing the virus titer
by approximately 2 log10 (Fig. 6B). Interestingly, apoptotic
cells were increased in virus-infected, Egr-1 knockdown cells as
compared to the control cells that were transfected with the
EGFP-siRNA (Fig. 6C). Although the increase was statistically
significant (p=0.037), the level of the increase was extremely
low, which may result from a number of factors. For example, in
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6A) but also was the virus replication (Fig. 6B). Thus, very low
level of virus replication might not be able to induce robust
apoptosis. Nevertheless, these results indicate that Egr-1 may
play a role in virus replication and cell survival.
Induction of Egr-1 gene expression by MHV infection was
correlated with the abilities of the viruses to cause persistent
infection
Both MHV-JHM and MHV-A59 are demyelinating-posi-
tive strains and can cause persistent infection in the CNS of
infected rodents, whereas MHV-2 is a non-demyelinating
strain and does not cause persistent infection. To test the
hypothesis in cell culture that cellular gene expression altered
by MHV infection may contribute to the control of virus
replication and persistence in CNS cells and consequently to
viral pathogenicity, we determined whether MHV strains with
distinctive pathogenic phenotypes have different abilities to
induce Egr-1 expression. DBT cells were infected with
different strains of MHV (including MHV-JHM, -A59 and
MHV2) or mock-infected. Total intracellular RNAs were
isolated at different time points p.i. as indicated, and the RNA
level of Egr-1 gene was determined by RT-PCR. As shown in
Fig. 7A, Egr-1 mRNA was induced (approximately 3 fold) by
both MHV-JHM and MHV-A59 at 8, 12, and 16 h p.i., but
not at 4 h p.i. In contrast, infection with MHV-2 failed to
induce Egr-1 expression as compared to those of mock-
infected cells (compare lanes 4, 8, 12, and 16 with lanes 1, 5,
9, and 13 in Fig. 7A). We also performed Western blot to
detect the protein expression. As presented in Fig. 7B, Egr-1
protein was significantly increased in both JHM- and A59-
infected cells (≈11- and 7-fold increase, respectively) but not
in MHV-2-infected cells. These data provide evidence that
correlates the ability of the MHV strains to induce Egr-1
expression with their ability to cause persistent infection in
the CNS cells and demyelinating disease in the animal CNS.
Discussion
In the present study, we have demonstrated that MHV
infection of DBT cells induced the expression of transcription
factor Egr-1 as determined by RT-PCR and Western blot.
These results confirmed our previous findings obtained from
DNA microarray analysis (Cai et al., 2003). As an immediate-
early gene, Egr-1 can be rapidly induced by a variety of
stimuli, including virus infections. Indeed, in addition to
MHV as found in this study, it has been shown that Egr-1
gene expression is induced by infections with diverse groups
of viruses. For example, Egr-1 expression was induced in the
brain tissue in experimental mice infected with Rabies virus
and Borna disease virus (BDV), in a number of human cells
infected with human foamy virus (HFV), in human T-cell
leukemia virus type 1-(HTLV-1) or type 2 (HTLV-2)-
transformed cell lines, in B-lymphocytes infected with
Epstein–Barr virus (EBV), and in Bc-2 cells latently infected
with Kaposi's sarcoma-associated herpesvirus (KSHV) (Fu etal., 1993; Wagner et al., 2000; Calogero et al., 1996; Wright
et al., 1990; Sukhatme et al., 1988).
How is the Egr-1 expression induced by virus infection? In
HTLV-transformed cells, it appears that the Tax protein is
responsible for the induction of Egr-1 expression (Fujii et al.,
1991). As a transactivator, Tax can interact with the transcrip-
tion factor CREB/ATF and serum response factors (SRFs)
(Suzuki et al., 1993; Fujii et al., 1992). These factors in turn
interact with the CREB/ATF response element (CRE) and
serum response element (SRE), respectively, on the promoter of
Egr-1, thus activating the expression of Egr-1 (Fujii et al., 1991;
Sakamoto et al., 1992). In the case of MHV-infected cells, we
demonstrated the activation of ERK by MHV infection and the
inhibition of Egr-1 expression by the MEK1/2 inhibitors (Figs.
4 and 3). Our results thus suggest that the induction of Egr-1
expression upon MHV infection is likely mediated through the
ERK signaling pathway. It is well established that the activation
of ERK can activate its downstream transcription factor Elk,
which then interacts with SRFs and activates a number of
immediate-early genes whose promoters contain an SRE.
Therefore, we postulate that the induction of Egr-1 by MHV
infection might follow the ERK1/2→Elk→SRFs→Egr-1
pathway. The upstream signal(s) that activates ERK1/2 has
not been determined in this study although the inhibitor that we
used to block ERK activation acts on the upstream kinase
MEK1/2. Nevertheless, our data suggest that the upstream
signal(s) most likely resides within or in the vicinity of the
cytoplasm membranes, which is activated during virus entry.
There are two pieces of evidence supporting this interpretation.
First, infection with UV-inactivated virus was still capable of
inducing Egr-1 transcription (Fig. 2). Second, ERK1/2 was
activated within 5 min upon virus entry and during the first 2 h
p.i. (Fig. 4). Although live virus is a stronger inducer for Egr-1
expression than UV-inactivated virus, ERK1/2 activation was
no longer detected at 3 h following infection (data not shown).
This suggests that although virus replication may play a role in
the induction of Egr-1 activation, the predominant signal that
activates Egr-1 expression is likely triggered during cell entry.
Activation of ERK1/2 has also been observed between 5 and
45 min p.i. in peritoneal exudative macrophage infected with
MHV-3 (McGilvray et al., 1998). Although Banerjee et al.
(2002) did not detect ERK1/2 activation after 2 h p.i., they did
not perform the same experiments at earlier time points.
Despite different mechanisms for Egr-1 induction by diverse
groups of viruses as discussed above, the finding that Egr-1 is
up-regulated by these different viruses may suggest that
infections by these viruses may have some common con-
sequences on both viruses and host cells. One of the potential
consequences is to facilitate virus replication in the host cells.
Indeed, knockdown of Egr-1 by siRNA significantly impaired
MHV propagation (Fig. 6B). It has also been reported that there
is a good correlation between Egr-1 and viral RNA expressions
in the mouse brains infected with Rabies and Borna disease
viruses, which raises the possibility that Egr-1 expression may
induce some phenotypic changes in neurons that render them
more susceptible to viral replication (Fu et al., 1993). The other
potential consequence of Egr-1 induction is to promote host cell
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induction of Egr-1 expression in EBV-infected B lymphocytes,
in EBV-transformed lymphoma and in HTLV-transformed cell
lines, may facilitate cell growth and may play a role in
tumorigenesis (Calogero et al., 1996; Fujii et al., 1991;
Sakamoto et al., 1992). It has also been suggested that the
expression of Egr-1 may change the phenotype of the infected
cells, which may help KHSV to establish latency (Sun et al.,
2001). By analogy, the induction of Egr-1 by MHV infection
may also facilitate the survival of the infected cells, thereby
promoting the establishment of MHV persistence in glial cells.
In support of this hypothesis is our finding that over-expression
of Egr-1 suppresses the expression of the pro-apoptotic gene
BNip3 (Fig. 5) that is down-regulated by MHV infection as
demonstrated in our previous study (Cai et al., 2003), whereas
knockdown of Egr-1 leads to apoptosis when cells are infected
with MHV (Fig. 6C).
The induction of Egr-1 expression by MHV infection may
also contribute to viral pathogenicity. Both JHM and A59 are
able to cause acute encephalitis and demyelination and
persistence in the CNS, whereas MHV-2 cannot. Recent studies
from our laboratory and others suggest that the ability of MHV
strains to cause acute encephalitis is correlated with their ability
to induce proinflammatory cytokines, particularly TNF-α and
IL-6, in primary mouse astrocytes and microglia (Li et al., 2004;
Yu and Zhang, in press). Interestingly, an Egr-1 binding site has
been found in the TNF-α promoter region; it has also been
shown that lipopolysaccharide (LPS)-induced expression of
TNF-α was mediated through the activation of Egr-1 by ERK1/
2 in macrophage (Kramer et al., 1994; Shi et al., 2002). Our
most recent study indicated that infection of primary mouse
astrocytes with JHM also induced Egr-1 expression (Cai and
Zhang, unpublished results). It remains to be seen whether Egr-
1 is involved in regulation of TNF-α induction by MHV
infection in these cells. In addition, it has been shown
previously that there is a general correlation between MHV
persistence and demyelination disease in the mouse CNS (Das
Sarma et al., 2000), which is also correlated with the ability of
MHV strains to induce Egr-1 expression as found in this study.
However, a firm establishment of such a correlation requires
further extensive experimentations in animals, i.e. using Egr-1
gene-knockout mice. Nevertheless, our current observation may
offer some interesting clues for future investigation on the
mechanism by which signal transduction pathways are
differentially regulated by MHV strains.
Materials and methods
Viruses, cells, antibodies, and reagents
MHV strain JHM (Makino and Lai, 1989) was used
throughout this study. In some experiments, MHV-A59 and
MHV-2 strains were also used. These viruses were kindly
provided by Dr. Michael Lai, and were propagated in the mouse
astrocytoma DBT cell line (Hirano et al., 1974). DBT cells were
also used for plaque assay and all other experiments involving
cell culture throughout this study. DBT cells were cultured in 1×minimum essential medium (MEM) containing 7.5% newborn
calf serum (NCS) (Gibco), 10% trypton phosphate broth (TPB)
and 1 mM of penicillin and streptomycin. Antibodies specific to
mouse Egr-1 protein and β-actin were purchased from Santa
Cruz Biochem. and Sigma, respectively. Antibodies specific to
total ERK1/2 and phosphorylated ERK1/2 were ordered from
Cell Signaling. MEK inhibitor UO126 was purchased from Cell
Signaling, Inc. JNK inhibitor SP600125 and p38 inhibitor
SB203580 were purchased from Calbiochem. ERK inhibitor CI-
1040 was a gift of Pfizer, Inc. The siRNA specific to Egr-1 (Egr-
1-siRNA) (Cat.# 040286-00) and to enhanced green fluores-
cence protein (EGFP-siRNA) (Cat.# 46-0926) were purchased
from Dharmocon, Inc. and Invitrogen, respectively.
Reverse transcription and polymerase chain reaction
(RT-PCR)
For detection of Egr-1 mRNAs, DBTcells were infected with
MHV-JHM at a multiplicity of infection (m.o.i.) of 5, or mock-
infected with serum-free medium. At various time points post-
infection (p.i.), intracellular total RNAs were isolated and
purified with the Trizol reagent (Invitrogen) according to the
protocol from the manufacturer. RNAs were then treated with
RNase-free DNase I (Promega) to remove the contaminated
genomic DNAs. The concentrations of the RNA samples were
determined by spectrophotometry (Hitatchi, Model 2100).
Maloney murine leukemia virus (MMLV) reverse transcriptase
(Promega) was used to reverse-transcribe the RNAs into cDNAs
with a random hexomer oligonucleotide primer (Invitrogen) in a
standard RT reaction as described previously (Zhang et al.,
1991). cDNAs were then used as templates for PCR amplifica-
tion with two pairs of primers specific for Egr-1 gene and β-
actin gene (as an internal control), respectively. The sense
primer for Egr-1 (5′Egr-1RT: 5′-ATG GCA GCG GCC AAG
GCC-3′) corresponds to a sequence at nucleotide (nt) 1–18 of
the open reading frame (ORF), and the anti-sense primer (3′Egr-
1-RT: 5′-GGG TAC GGT TCT CCA GAC CCT-3′) is
complementary to a sequence at nt 818–838 according to the
published sequence (GenBank accession number: NM007913).
The PCR product is 838 nt in length. The primer pair for β-actin
is 5′mb-actin (5′-ACC AAC TGG GAC GATATG GAG AAG
A-3′, corresponding to the sequence at nt 229–253) and 3′mb-
actin (5′-TAC GAC CAG AGG CAT ACA GGG ACA-3′,
complementary to a sequence at nt 418–442 of the β-actin gene)
(GenBank accession number: NM007393). The PCR product
for the β-actin gene is 214 nt in length. PCR was carried out in a
reaction of 20 μl containing 1× PCR buffer (20 mM Tris–HCl,
pH 8.3, 25 mM KCl, 1.5 mMMgCl2, 0.1% Tween-20), 200 μM
each of the four dNTPs, 20 pM of primers, 3 U of Taq DNA
polymerase, and 2 μl of the RT products as templates for 30
cycles with each cycle consisting of denaturing at 95 °C for 20 s,
annealing at 55 °C for 1 min, and extension at 72 °C for 1 min
with a final extension of 10 min. PCR was performed in a
thermocycler DNA Engine (Model PTC-200, MJ Research).
PCR products were analyzed by agarose gel electrophoresis,
and the gels were stained with ethidium bromide and
photographed with a UVP gel document center.
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MHV-JHM strain was exposed to UV light for 20 min on ice
in a UV-crosslinker (Fisher Scientific). Inactivation was
confirmed by titration of samples in DBT cells before and
after UV–light exposure, and by the absence of cytopathic
effect after inoculation of DBT cell monolayers with UV-
irradiated virus.
Western blot analysis
DBT cells were grown to monolayer in 60-mm Petri dishes
and were infected with MHV strains JHM, A59, or MHV-2 or
mock-infected with serum-free medium. At different time
points p.i., cells were harvested and lysed in 50 μl of strong
lysis buffer (25 mM HEPES, pH 7.5, 0.5% sodium deoxycho-
late, 1% Triton X-100, 0.2% SDS, 5 mM EDTA, 1 mM
Na3VO4, 20 mM β-glycerophosphate, 50 mM NaF) containing
protease inhibitor cocktail tablets (Roche). The lysates were
sonicated 3 times for 20 s each on ice. The protein concentration
was measured by using Bio-Rad protein assay kit (Bio-Rad,
CA). Equal amounts of cell lysates were boiled for 5 min,
chilled on ice, and pelleted by centrifugation before loading
onto gels. Proteins were separated by SDS-polyacrylamide gel
(10%) electrophoresis (PAGE). The proteins were then
transferred to nitrocellulose membrane (MSI, Westborough,
MA) for 7 h at 40 V in a transfer buffer (25 mM Tris, 200 mM
glycine, 20% methanol, 0.02% SDS). After being blocked with
5% skim milk in Tris-buffered saline (TBS) for 1 h at room
temperature (RT), the membrane was washed three times in
TBS containing 0.5% Tween-20 and immunoblotted with a
primary antibody (1 μg/ml) for 2 h at RT, followed by a
secondary antibody coupled to horseradish peroxidase (1:1000
dilution) (Sigma) for 1 h at RT. The presence of the interested
protein was detected by enhanced chemiluminescence (ECL)
using peracid as a substrate (Amersham) followed by
autoradiography.
Construction of plasmid DNA
For cloning of the Egr-1 gene, RNAs were isolated from
DBT cells and cDNAs were synthesized by RT using the
random hexomer primer as described above. The Egr-1 gene
was amplified by PCR using the sense primer 5′Egr-1ORF
(5′-TTT GAA TTC GGG ATG GCA GCG GCC AAG G-3′,
corresponding to the first 16 nt of the Egr-1ORF, GenBank
accession number NM007913), which contains an EcoRI site
at the 5′-end (underlined), and the anti-sense primer 3′Egr-
1ORF (5′-TTT CTC GAG GCA AAT TTC AAT TGT CCT
GGG-3, complementary to the last 21 nt of the Egr-1 ORF),
which contains an XhoI site (underlined). The PCR products
were directly cloned into pCR2.1 TA cloning vector
(Invitrogen), resulting in pTA-Egr-1. The sequence of the
clone was confirmed by automatic DNA sequencing (IBI,
Prizm-377) in the Departmental Core Facility. pTA-Egr-1
DNA was then digested with EcoRI and XhoI and direction-
ally cloned into the EcoRI and XhoI sites of the plasmidpcDNA3 (Invitrogen), generating pcDNA3/Egr-1. To generate
pBS-CMV-Egr-1 plasmid, the pcDNA3/Egr-1 DNA was
digested with EcoRI and XbaI and directionally cloned into
the EcoRI and XbaI sites of the plasmid pBS-CMV.
DNA transfection and assays for luciferase and
beta-galactosidase activities
For DNA transfection, the LipofectAmine reagent was
used according to the manufacturer's instruction (Invitrogen).
Briefly, DBT cells were seeded in a 24-well culture plates at a
density of 4×105 cells per well. When the cells reached to
approximately 60% confluency, ≈500 ng of plasmid DNAs
and 3 μl of the LipofectAmine reagent were diluted separately
in 100 μl of serum-free OPTI medium without antibiotics,
mixed, and incubated at RT for 30 min before adding to each
well of the 24-well plate. DBT cells were washed with PBS
and 300 μl of OPTI medium was added to each well of the
cell culture. The DNA-lipofectAmine mixture (200 μl) was
added to each well and the cell culture plates were incubated
at 37 °C for various time periods as indicated. For luciferase
assay, cells were harvested along with culture medium and
lysed by freezing and thawing. The cell lysate (100 μl) was
assayed for luciferase activity using the luciferase assay
system (Promega) in a microtiter plate luminometer (Dynex
Technologies). For β-galactosidase assay, the medium was
removed and the monolayers were washed twice with PBS
after 24 h post-transfection. The cells were harvested into
microfuge tubes by scraping the cells. The cells were
recovered by centrifugation at 12,000×g for 10 s at RT.
125 μl lysis buffer (0.25 M Tris–HCl, pH 8.0) was added into
the tubes. The cells were lysed by freezing at −70 °C and
thawing at 37 °C three times. The cell extract was recovered
by centrifuging at 12,000×g for 5 min at 4 °C. For each
sample to be assayed, the following reagents were mixed
together: 3 μl of 100× Mg solution (0.1 M MaCl2, 4.5 M β-
mercaptoethanol), 66 μl of 1× ONPG (o-nitrophenyl-β-D-
galactopyranoside), 30 μl of cell extract and 201 μl of 0.1 M
sodium phosphate (pH 7.5). The reaction was incubated at
37 °C for 30 min. The reaction was then stopped by adding
500 μl of 1 M Na2CO3. The optical density of the reaction
was read at a wavelength of 420 nm.
Detection of apoptotic cells
Apoptosis was determined by counting the apoptotic nuclei
under a microscope following propidium iodide staining as
described previously (Liu et al., 2003). Apoptosis was
expressed as mean percentage of the cell population and
standard deviation of three independent experiments.
Statistical analysis
The results are expressed as mean±standard deviation (SD)
and the mean values were compared using Student's t test.
Values of p<0.05, p<0.01, and p<0.001 were considered
statistically significant.
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